GMP Biopharma Capabilities Polymun is a contract development and manufacturing organization with current GMP compliance and an Austrian production license for pharmaceuticals, enabling end-to-end manufacturing for biopharmaceuticals, biosimilars, and complex formulations such as liposomal/LNP products.

Platform for Partnerships Active involvement in high-profile collaborations (e.g., BioNTech/Pfizer COVID-19 vaccine) demonstrates readiness and credibility for partner-driven programs, potential for scale-up, and cross-border projects.

Diverse Product Expertise Experience fabricating biosimilars, research reagents for HIV antibodies/antigens, and contract development for biopharmaceuticals, suggesting opportunities across vaccines, biologics, and diagnostics collaborations.

Small-to-Mid Cap Advantage With a lean employee base and revenue in the low millions, Polymun offers agility, faster decision cycles, and customized CDMO services appealing to mid-market biotech firms seeking flexible manufacturing partners.

Growth Through Reagents Existing distribution of HIV antibodies/antigens as research reagents indicates an avenue to expand sales into core reagents supply for labs and academic customers, complementing GMP manufacturing capabilities for integrated programs.